- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Dymista ( Fluticasone/Azelastine )
Dymista (fluticasone propionate and azelastine hydrochloride) is a fixed‑dose combination nasal spray containing an intranasal corticosteroid and a second‑generation antihistamine. It is indicated for the symptomatic treatment of moderate to severe seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older when monotherapy with either an intranasal antihistamine or an intranasal corticosteroid is considered insufficient. Fluticasone propionate reduces nasal inflammation by inhibiting multiple inflammatory mediators, while azelastine hydrochloride blocks H1 receptors, providing rapid relief of itching, sneezing, rhinorrhea, and nasal congestion. Dymista is intended for regular twice‑daily use and may provide both rapid symptom improvement and sustained anti‑inflammatory control.
Usual adult dose: The recommended dose is one spray in each nostril twice daily (morning and evening). The bottle should be gently shaken before each use, and the device must be primed before first use or if not used for 3 days. Patients should be instructed to blow their nose gently, tilt the head slightly forward, and avoid inhaling deeply while spraying. After use, the nozzle should be wiped with a clean tissue. The maximum daily dose is two sprays per nostril. If a dose is missed, the patient should take the next dose at the usual time; two doses must not be taken at the same time. Use should be continued regularly for full benefit, even when symptoms improve. In Canada, Dymista is available only by prescription.
Dosage form: Nasal spray suspension: each metered actuation delivers 50 mcg of fluticasone propionate and 137 mcg of azelastine hydrochloride (equivalent to 140 mcg azelastine hydrochloride as commonly rounded; the user‑specified strength 50/140 mcg is consistent with this formulation). The product is supplied in a glass bottle fitted with a metered‑dose manual spray pump, delivering 120 metered sprays after priming.
Onset of action: The antihistamine component (azelastine) begins to relieve nasal symptoms within 15 to 30 minutes after the first dose. The corticosteroid component (fluticasone) has a slower onset; clinically meaningful improvement in nasal congestion and overall symptom control typically develops after 2 to 4 days of continuous twice‑daily use, with maximum benefit achieved after 1 to 2 weeks.
Duration of action: The combination provides symptom control over a 12‑hour dosing interval, supporting twice‑daily administration. Regular use maintains sustained anti‑inflammatory and antihistaminic activity; the elimination half‑life of azelastine is approximately 22 hours and fluticasone propionate is approximately 7.8 hours after intranasal administration, but the clinical effect is governed by local receptor occupancy and anti‑inflammatory action.
Alcohol recommendation: Alcohol should be used with caution during treatment with Dymista. Azelastine may cause somnolence, and alcohol can potentiate this central nervous system depressant effect, leading to increased drowsiness, dizziness, and impaired judgment. Patients should avoid or limit alcohol intake, especially when first starting therapy or if they experience significant sedation.
Most common side effects: Dysgeusia (bitter or altered taste, reported in up to 10% of patients), epistaxis (nosebleeds), headache, nasal irritation or dryness, sneezing, and somnolence. Bitter taste can be minimized by instructing the patient to avoid tilting the head back during administration and to sniff gently after spraying. Epistaxis is generally mild; persistent or severe bleeding should be reported. Dymista is contraindicated in patients with known hypersensitivity to fluticasone propionate, azelastine, or any component of the formulation. Caution is advised in patients with tuberculosis, untreated fungal, bacterial, or viral infections, or ocular herpes simplex. Intranasal corticosteroids may cause an increased risk of localized Candida albicans infection, especially with long‑term use. Systemic corticosteroid effects including growth retardation, adrenal suppression, and increased intraocular pressure are rare at recommended doses but may occur with high‑dose or prolonged therapy. Patients who are pregnant or breastfeeding should consult a healthcare professional before use. Dymista is not indicated for the relief of acute asthma or for use in children under 12 years of age.
Would you like to try Dymista (Fluticasone/Azelastine) without a prescription?
Buy Generic Dymista (Fluticasone/Azelastine) without prescription in Canada
At our pharmacy, you can buy Dymista without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.
What is Dymista?
Dymista is a prescription nasal spray that combines two active ingredients in one device: azelastine hydrochloride, an antihistamine, and fluticasone propionate, a corticosteroid. It is used to treat seasonal allergic rhinitis, also known as hay fever, and year-round allergic rhinitis. Allergies happen when your immune system overreacts to things like pollen, dust mites, or pet dander. That overreaction releases histamine and other inflammatory chemicals, causing sneezing, itching, a runny nose, and congestion. Azelastine blocks histamine at the receptor level, providing fast relief. Fluticasone reduces the underlying inflammation that makes the nose stuffy and swollen. Together, they attack the problem from two directions.
This is a maintenance medication, not a rescue spray like a decongestant. You use it every day during your allergy season, or year-round if your allergies never quit. The effect builds over several days. Some people notice the antihistamine effect within 30 minutes, but the full anti-inflammatory benefit of the steroid component takes up to a week. Dymista is a unique product because no other prescription nasal spray combines an antihistamine and a steroid in a single bottle. The standard dose is one spray in each nostril twice daily. Each spray delivers 50 mcg of azelastine and 140 mcg of fluticasone. Dymista is manufactured by Mylan and is available as a generic under the name azelastine/fluticasone.
Mechanism and Pharmacology
Azelastine is a second-generation antihistamine, but unlike oral antihistamines, it is delivered directly to the nasal mucosa. It blocks H1 receptors, preventing histamine from triggering sneezing, itching, and mucus production. It also stabilizes mast cells, reducing the release of histamine and other inflammatory mediators. The effect begins quickly, often within 15 to 30 minutes of a dose. Fluticasone propionate is a corticosteroid that enters the cells of the nasal lining, binds to glucocorticoid receptors, and changes gene expression. It suppresses the production of cytokines, chemokines, and other inflammatory proteins. It reduces the influx of eosinophils, mast cells, and T-cells into the tissue. The result is less swelling, less mucus, and a calmer nasal passage. This anti-inflammatory effect takes longer to build, but it addresses the root of the congestion that antihistamines alone often miss.
The two drugs have complementary mechanisms. The antihistamine handles the immediate allergic reaction, while the steroid quietens the chronic inflammation. When combined in a single spray, they provide better symptom control than either drug alone. After intranasal administration, azelastine reaches peak plasma levels in about 2 to 3 hours, and fluticasone in about 1 to 2 hours. The systemic absorption of both drugs is low. Azelastine is metabolized in the liver by CYP3A4, and fluticasone is metabolized by CYP3A4 as well, though the swallowed portion undergoes extensive first-pass metabolism. The half-life of azelastine is about 22 hours, and the half-life of fluticasone is about 8 hours after intranasal administration. Both are excreted primarily in the feces. Because systemic exposure is minimal, the risk of systemic side effects is low.
How to Use Dymista
The standard dose is one spray in each nostril twice daily. Shake the bottle gently before each use. Before the first use, prime the pump by spraying it into the air until a fine mist appears. This usually takes several pumps. Blow your nose gently to clear it. Tilt your head forward slightly. Insert the nozzle into one nostril, aim it away from the center of the nose, and spray while breathing in gently. Repeat in the other nostril. Avoid blowing your nose for a few minutes after using the spray. Wipe the nozzle with a clean tissue and replace the cap. Do not use more than the prescribed dose. More is not better and increases the risk of side effects like headache and nosebleeds.
If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed one and continue on your regular schedule. Do not double up. Dymista works best when used consistently. It is not a spray you use only on bad days. During allergy season, use it every day, even if you feel fine, because the anti-inflammatory effect needs to build and stay steady. If you stop and start, the inflammation returns. The spray can be used long-term under medical supervision. Your doctor will monitor your nasal passages if you use it for months at a time. If you are using other nasal sprays, ask your doctor how to space them. If you use a saline rinse, do it before Dymista, not after. If you develop a nosebleed, stop using the spray for a few days and let the nasal lining heal.
Side Effects of Dymista
The most common side effect is a bitter or unpleasant taste in the mouth after using the spray. This is caused by the azelastine draining down the back of the throat. It is harmless and can be reduced by sniffing gently after spraying, rather than inhaling deeply. Headache is also common. Nosebleeds, nasal irritation, and a feeling of dryness or burning inside the nose can occur. These are usually mild and improve with continued use. Using a saline nasal spray or gel before applying Dymista can help moisturize the lining and reduce irritation. Sneezing right after using the spray is possible but usually settles.
More serious but rare side effects include perforation of the nasal septum, a hole in the wall between the nostrils. This is more likely with long-term steroid use, especially if the spray is aimed directly at the septum. Aiming away from the center reduces this risk. Glaucoma and cataracts can occur with long-term systemic steroid exposure, but the intranasal dose of fluticasone is low, and the risk is small. However, anyone with a history of these conditions should be monitored. Allergic reactions, including rash and swelling, are rare. If the spray causes severe nosebleeds, persistent pain, or vision changes, stop and see your doctor. Azelastine can cause drowsiness in some people, though less so than older antihistamines. If you feel sleepy after using it, avoid driving until you know how it affects you.
High-Risk Groups (Elderly, Pregnancy)
Pregnancy. Dymista is pregnancy category C. Azelastine and fluticasone have been used during pregnancy, but the combination has not been studied in large pregnant populations. Fluticasone has reassuring data from use as a standalone nasal spray. Azelastine has less data but is generally considered low risk because the systemic absorption is minimal. The benefit of treating allergic rhinitis during pregnancy, especially if it interferes with sleep and breathing, often outweighs the theoretical risk. Budesonide is the preferred intranasal steroid in pregnancy because it has the best safety data, but Dymista may be used if the antihistamine component is needed. Discuss with your obstetrician. Breastfeeding. Both azelastine and fluticasone pass into breast milk in small amounts. The relative infant dose is low. Dymista is considered compatible with breastfeeding by most experts, but the infant should be monitored for drowsiness or poor feeding. Do not apply the spray to the nipple area. Elderly patients can use Dymista without dose adjustment. They may be more prone to nosebleeds, especially if they are on anticoagulants or have fragile nasal mucosa. The bitter taste and drowsiness from azelastine may also be more noticeable. Patients with a history of glaucoma, cataracts, or nasal surgery should discuss the risks with their doctor. Children under 6 years have not been studied extensively, and the product is approved for patients 6 years and older. Those with severe liver impairment should use Dymista with caution because both drugs are metabolized in the liver, though the systemic exposure is low.
Interaction With Activities (Driving, Alcohol)
Dymista can cause drowsiness, dizziness, and fatigue in some people, mainly due to the azelastine component. If you experience these, do not drive or operate machinery until they resolve. The effect is usually mild and improves over time, but it can be significant in sensitive individuals. Alcohol can increase the drowsiness and dizziness caused by azelastine. It is best to avoid alcohol or limit it while using Dymista, especially when you first start or when your dose is increased. Even a single drink can make you sleepier than expected. If you are using the spray during allergy season and you drink, do so with caution and never before driving.
Drug Interactions
Dymista has few systemic interactions because the drugs are delivered intranasally and absorption is low. The main interaction is with other central nervous system depressants. Azelastine can add to the sedative effects of alcohol, benzodiazepines, opioids, sleeping pills, and sedating antihistamines. If you take any of these, the combination can make you very drowsy and impair your coordination. Avoid or limit these combinations. Cimetidine, a stomach acid reducer, can increase the blood levels of azelastine, but the clinical significance is small. Fluticasone is metabolized by CYP3A4. Strong inhibitors of this enzyme, like ritonavir, ketoconazole, and clarithromycin, can increase fluticasone levels, but again, the intranasal dose is low. No routine dose adjustment is needed. There are no known interactions with oral antihistamines, decongestants, or asthma inhalers. Always tell your doctor and pharmacist about all medicines and supplements you take, but be reassured that Dymista is well tolerated in most combinations.
Alternative Options
For allergic rhinitis, several alternatives exist. Oral antihistamines like cetirizine, loratadine, and fexofenadine are effective for sneezing and itching but less effective for congestion. Nasal steroid sprays like fluticasone, mometasone, and budesonide are excellent for congestion and inflammation but take days to work. Dymista combines both classes in one spray, which is convenient and often more effective than either alone. A nasal antihistamine spray like azelastine alone is also available and works faster than a steroid alone. For severe allergies, oral leukotriene inhibitors like montelukast can be added. Immunotherapy, either allergy shots or sublingual tablets, is the only treatment that changes the immune response over time. Decongestant sprays like oxymetazoline are effective for short-term use only, as they cause rebound congestion if used more than 3 days. The choice depends on the severity of symptoms, the seasonality, and patient preference. Dymista is particularly useful for people with moderate to severe allergic rhinitis who want the convenience of a single spray and the combined power of an antihistamine and a steroid.
INN, Brand Names, and Classification in Canada
INN (International Nonproprietary Names): Azelastine hydrochloride and Fluticasone propionate
Available brand names in Canada: Dymista, and generic azelastine/fluticasone nasal spray
ATC code: R01AD58
Forms and strengths: Nasal spray suspension delivering 50 mcg azelastine hydrochloride and 140 mcg fluticasone propionate per actuation. Bottles of 120 metered sprays.
Manufacturers: Mylan Pharmaceuticals ULC (Dymista), and generic manufacturers including Apotex Inc. and Teva Canada Limited.
Registration status in Canada: Registered
Classification: Prescription (Rx)
Frequently Asked Questions
How fast does Dymista start working?
The azelastine component begins blocking histamine within 15 to 30 minutes, so you may feel quick relief from sneezing and itching. The fluticasone component takes longer, with full effect building over several days to a week. Use it consistently every day for best results.
Why do I get a bitter taste after using the spray?
The bitter taste is the azelastine draining down the back of your throat. It is harmless. To reduce it, tilt your head forward slightly and sniff gently after spraying, rather than inhaling deeply. Some people find that drinking a small amount of water afterward helps wash the taste away.
Can I use Dymista year-round?
Yes, if you have perennial allergies to dust mites, mold, or pet dander, you can use it every day. The safety profile is good for long-term use. Your doctor will check your nasal passages periodically to make sure the lining is healthy and that no nosebleeds or irritation are developing.
Is Dymista a steroid?
It contains a steroid, fluticasone, but it is not only a steroid. The azelastine is an antihistamine. The combination is why it works better for many people than a steroid spray alone. The steroid dose is low and acts locally in the nose, with minimal systemic absorption.
Can I use Dymista with my asthma inhaler?
Yes, the drugs do not interact. Many people with allergic rhinitis also have asthma, and using both treatments is standard. The nasal spray and the inhaler work in different parts of the respiratory system. Always keep your rescue inhaler with you.
Delivery Information Across Canada
We ship Dymista and generic azelastine/fluticasone nasal spray to all provinces and territories. Delivery times vary depending on how remote your location is:
- Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
- Quebec (Montreal, Quebec City, Laval): 5 to 7 days
- British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
- Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
- Manitoba (Winnipeg, Brandon): 5 to 9 days
- Saskatchewan (Saskatoon, Regina): 5 to 9 days
- Nova Scotia (Halifax, Sydney): 5 to 9 days
- New Brunswick (Moncton, Fredericton): 5 to 9 days
- Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
- Prince Edward Island (Charlottetown): 7 to 14 days
- Yukon, Northwest Territories, Nunavut: 7 to 14 days
All shipments are packed discreetly with no branding or indication of contents on the outside.
| Shipping method | Delivery time | Price | |
Delivery |
14-21 days | 14.95$ | Tracking# available in 4 days |
Delivery |
9-14 days | 30$ | Tracking# available in 2 days |
- Shipping worldwide
- Confidentiality and anonymity guarantee
- Safe and secure
- Discrete looking packages
- Dispatch orders within 24 hours
- 100% success delivery
